| Haley Brynne Hlela, MSN, ACCNS-P, CPHQ | |
|
3500 Civic Center Blvd, Philadelphia, PA 19104-4395 | |
| (215) 264-3142 | |
| Not Available |
| Full Name | Haley Brynne Hlela |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Pediatrics |
| Location | 3500 Civic Center Blvd, Philadelphia, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417733635 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0200X | Clinical Nurse Specialist - Pediatrics | CNS000287 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Haley Brynne Hlela, MSN, ACCNS-P, CPHQ 3500 Civic Center Blvd, Philadelphia, PA 19104-4395 Ph: (215) 264-3142 | Haley Brynne Hlela, MSN, ACCNS-P, CPHQ 3500 Civic Center Blvd, Philadelphia, PA 19104-4395 Ph: (215) 264-3142 |
News Archive
The U.S. Environmental Protection Agency will continue validating its ToxCast screening tool by screening more than 100 drugs provided by Pfizer, GlaxoSmithKline, Sanofi-Aventis, and Merck. These drugs never entered the marketplace because they demonstrated different types and levels of toxicity when the pharmaceutical companies conducted the early stage clinical trials required by the Food and Drug Administration as part of the drug development process.
World Congress of Cardiology Report - Pacemaker treatment for bradycardia is frequently used with more than 500,000 people worldwide receiving a cardiac pacemaker each year.
Intellect Neurosciences, Inc., a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced today that its Chairman & CEO, Dr. Daniel Chain, was granted a patent by the European Patent and Trademark Office related to the use of insulin sensitizers for the prevention and treatment of memory loss and dementia. Insulin sensitizer drugs include Rosiglitazone and Pioglitazone, which have been approved for the treatment of type II diabetes mellitus.
By artificially activating the brain's reward system, researchers at the Technion-Israel Institute of Technology have dramatically reduced the size of cancerous tumors in mice. The findings were published recently in the journal Nature Communications.
People can become allergically sensitized straight from birth. "Early screening is therefore important to detect allergies early so that steps can be taken to prevent serious forms of illness developing," say the MedUni Vienna allergy researchers, speaking on the occasion of World Immunology Day on 29 April and the current WHO World Immunization Week.
› Verified 5 days ago
Ms. Martha M. Dooley, MSN RN CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 120 S 30th St, 5th Floor, Philadelphia, PA 19104 Phone: 215-386-5128 Fax: 215-382-3626 | |
Caitlin Clason, WHNP-BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1632 Pine St, Philadelphia, PA 19103 Phone: 215-735-7992 | |
Lauren Marie Heimall, MSN, RN, PCNS-BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 3401 Civic Center Blvd, Philadelphia, PA 19104 Phone: 215-796-3893 | |
Ms. Cynthia Rene Owens-manns, MSN, RN, CNS-BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 3900 Woodland Ave, Philadelphia, PA 19104 Phone: 215-823-7811 Fax: 215-222-2593 | |
Mrs. Jessica Lynne Smith, RN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 5501 Old York Rd, Philadelphia, PA 19141 Phone: 215-456-7014 | |
Marie Wojcik, RN, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 3900 Woodland Ave, Philadelphia, PA 19104 Phone: 215-823-5800 | |
Mr. Thomas R Hatala, CRNA Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 3998 Red Lion Rd, Philadelphia, PA 19114 Phone: 201-612-4088 Fax: 215-612-4323 |